Consistently, the ectopic expression of RAC1P29S in melanoma cell lines increases resistance to BRAF and MEK inhibitor therapies (Van Allen et al., 2014; Watson et al., 2014; Araiza-Olivera et al., 2018). This evidence concerns the gene BRAF and melanoma.